14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Alzheimer Disease in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "One of the prominent features of Alzheimer's disease is the excessive accumulation of the protein amyloid beta (Aβ) in certain areas of the brain leading to neurodegeneration." | 1.37 | Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain. ( Harder, DR; Narayanan, J; Sarkar, P, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarkar, P | 1 |
| Narayanan, J | 1 |
| Harder, DR | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Alzheimer Disease
| Article | Year |
|---|---|
Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain.
Topics: 8,11,14-Eicosatrienoic Acid; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Br | 2011 |